A critical enzyme for sperm formation could be a target for treating male infertility

While some of our body’s cells divide in a matter of hours, the process of making sperm, meiosis, alone takes about 14 days from start to finish. And fully six of those days are spent in the stage known as the pachytene, when pairs of chromosomes from an individual’s mother and father align and connect.

“This stage is really important, because the pair needs to be aligned for the exchange of genetic material between those two chromosomes,” says P. Jeremy Wang, a biologist in Penn’s School of Veterinary Medicine. “If anything goes wrong at this stage, it can cause a defect in meiosis and problems in the resulting sperm, leading to infertility, pregnancy loss, or birth defects.”

In a new paper in Science Advances, Wang and colleagues have identified an enzyme that plays a crucial role in maintaining this chromosomal pairing during the pachytene stage of meiosis. Without this protein, named SKP1, meiosis cannot proceed to metaphase, the next major developmental stage involved in generating sperm cells.

The finding may help overcome hurdles that have stood in the way of treating certain forms of male infertility, in which a man makes no sperm but in whom sperm’s precursor cells, spermatogonia, can be found.

“Reproductive technologies like in vitro fertilization have made a huge difference for infertile patients, but the male needs to have at least some sperm,” says Wang. “If the male has no sperm, then the only option is to use donor sperm. But if you can find these spermatogonia, the pre-meiotic germ cells, they could be induced to go through meiosis and make sperm. So SKP1 could be part of the solution to ensuring meiosis continues.”

Wang is also hopeful that his finding could aid in basic research on sperm development that his and many other labs pursue.

“Right now we use animals to do our research; we don’t have a cell culture system to produce sperm,” he says. “Manipulating SKP1 and the pathway in which it acts could allow us to set up an in vitro system to produce sperm artificially, which would be a boon for our studies.”

The publication represents nearly a decade of work, led by Wang’s postdoctoral researcher Yongjuan Guan, with major contributions from former postdoc Mengcheng Luo.

The team began focusing on SKP1 after conducting a screening test to look for proteins found in the area where the paired chromosomes come together during the pachytene stage of meiosis. From earlier studies, the researchers knew that SKP1 also plays a role in cell division in cells throughout the body, not just sperm and eggs. Without it, cells die.

That fact forced the Penn Vet team to get creative to understand the protein’s function. Unable to simply eliminate it, they created a model system in mice in which they could turn off the protein only in the germ cells and only in adulthood.

“Taking this inducible, germ-cell-specific model, we found that taking away SKP1 caused the chromosomes to prematurely separate,” says Wang.

While the normal alignment process in the pachytene stage takes six days in mice, in the cells that lost SKP1 the paired chromosomes separated far earlier.

Scientists had hypothesized the existence of a metaphase competence factor, or some protein required for a cell to enter metaphase. Wang believes that SKP1 is it.

While introducing a compound known as okadaic acid to sperm precursor cells can coax them into an early entrance to metaphase, cells lacking SKP1 did not progress to metaphase.

Experiments in developing eggs showed the researchers that SKP1 is also required for females to maintain viable eggs. Oocytes, the cells that develop through meiosis to form mature eggs, that lacked SKP1 developed misaligned chromosomes and many eventually were lost.

In future work, Wang and his colleagues want to dig deeper into the mechanism of action by which SKP1 works to ensure cells can progress to metaphase, with the idea of eventually manipulating it to find strategies for addressing infertility and innovative laboratory techniques.

“Now that we know SKP1 is required, we’re looking for the proteins it interacts with upstream and downstream so we can study this pathway,” says Wang.

Share Button

Improving cleanup of contaminated groundwater

Beads that contain bacteria and a slow-release food supply to sustain them can clean up contaminated groundwater for months on end, maintenance free, research by Oregon State University shows.

The hydrogel beads, which have the consistency of gummy candy and are made with an ingredient used in processed foods, hold the promise for sustained cleanup of groundwater contaminated with dangerous and widely used volatile organic compounds; many of the compounds are listed by the Centers for Disease Control and Prevention as likely human carcinogens.

At multiple locations around the country, the chemicals are present at concentrations that far exceed state and federal standards for safe drinking water.

Among the contaminants addressed in the study are 1,1,1-trichloroethane, cis-1,2-dichloroethene, and 1,4-dioxane — degreasers commonly used by industry and the military. The chemicals can infiltrate groundwater through leaky underground storage tanks or runoff, or by simply being dumped on the ground as they were in past.

The new decontamination method, developed through a collaboration between the OSU College of Engineering and North Carolina State University, works because the microbes produce an enzyme that oxidizes the toxins when groundwater contaminants diffuse into the beads.

The result is a transformation of the contaminants into harmless compounds.

“We’ve created a process called long-term aerobic cometabolism, which is an enclosed, passive, self-sustaining system for groundwater remediation,” said OSU’s Lew Semprini, distinguished professor of environmental engineering and principal investigator on the study. “The beauty of this is that everything happens inside the beads.”

Current practices, Semprini explains, call for gaseous growth substrates such as propane and methane to be added directly to the subsurface. The substrates nourish indigenous microbes, which in turn produce enzymes that transform the contaminants to non-toxic byproducts.

Often, however, the growth substrates chemically compete for those crucial enzymes, which significantly inhibits the transformation process.

The new system eliminates that competition, freeing all of the enzyme to oxidize contaminants.

“We’ve flipped the paradigm on its head by putting the right microorganism inside hydrogel beads and supplying it with a slow-release food source,” Semprini said. “To my knowledge, this is the first time it’s been done.”

The study appears in Environmental Science: Processes & Impacts.

Semprini and his research team co-encapsulated the bacteria culture Rhodococcus rhodochrous and a slow-release growth substrate within hydrogel beads that they produced in the lab. The cylindrical beads, made of gellan gum, a common ingredient in processed foods, are 2 millimeters long.

As groundwater flows by the beads, the contaminants diffuse into the beads, where the slow release substrate reacts with groundwater to produce alcohol that sustains the Rhodococcus bacteria. The bacteria contain a monooxygenase enzyme that transforms the contaminants into harmless compounds, including carbon dioxide, water and chloride ions.

The purified water and the byproducts then diffuse out of the beads and rejoin the groundwater plume.

In bead-filled test columns supplied with a continuous flow of contaminated water, the system functioned continuously for more than 300 days (and counting) on the original growth substrate.

Semprini found that the beads remove more than 99% of the contaminants, and their concentrations declined from several hundred parts per billion to less than 1 part per billion.

The system’s longevity will depend mainly on how long the bacteria live, which is a factor of how long the growth substrate lasts. That has yet to be determined.

“It’s a question for future research,” Semprini said. “How do we make beads that last many years, or how do we develop systems that can easily be replaced?”

Current cometabolic remediation methods require regular additions of growth substrates to ensure that key microorganisms flourish, and that necessitates regular site monitoring, biochemical adjustments and related costs.

The next step is to scale up the system and conduct pilot studies in the field.

Semprini envisions several possibilities for deploying the beads. One option is mixing beads directly into contaminated subsurface material. Another is to dig a trench in the path of groundwater flow and fill it with beads, creating a permeable reactive barrier. A third possibility is packing beads into reactors, a simple form being mesh bags, that can be placed in wells.

“Everybody favors sustainability in this type of system: Can we just have something working in the subsurface without much maintenance?” Semprini said. “I think we’ve achieved that.”

The study was funded by the Department of Defense.

Share Button

Coronavirus: Prince Charles tests positive but ‘remains in good health’

The Prince of Wales, 71, has mild symptoms but “otherwise remains in good health,” Clarence House says.

Share Button

Coronavirus: Government orders 10,000 ventilators from Dyson

The engineering firm developed a new type of ventilator in response to calls on behalf of the NHS.

Share Button

Health24.com | Are people with blood type A more vulnerable to contracting the new coronavirus?

According to a recent study, people with type A blood may have a higher chance of contracting the new coronavirus. The study, which can be viewed on medRxiv, was carried out by a group of 19 Chinese researchers and examined 2 173 patients with Covid-19. The patients were from hospitals in Wuhan and Shenzhen.

The researchers then analysed the distribution of blood types in the normal population in each area and compared it to their sample of patients with the virus, also in each area, reports Science Alert. The authors concluded:

“People with blood group A have a significantly higher risk for acquiring Covid-19 compared with non-A blood groups,” their report reads, adding: “Whereas blood group O has a significantly lower risk for the infection compared with non-O blood groups.”

How reliable is this information?

The team mentions that their study is a pre-print and has not been peer-reviewed. This means it has yet to be evaluated and should therefore not be used as clinical guidance.

According to the study, Wuhan’s normal population has the following blood type distribution:

  • 31% type A
  • 24% type B
  • 9% type AB
  • 34% type O

By comparison, those with the virus were:

  • 38% type A
  • 26% type B
  • 10% type AB
  • 25% type O

To put it into further context, the study also states that 85 out of 206 patients who died of Covid-19 in Wuhan had blood type A – this was 63% more than people with blood type O who died.

The preliminary study notes that similar differences were observed in Shenzhen and found that age and gender do not play a major role. 

Lead researcher Wang Xinghuan wrote: “It might be helpful to introduce ABO blood typing in both patients and medical personnel as a routine part of the management of SAR-CoV-2 (the Covid-19 virus) and other coronavirus infections to help define the management options and assess risk exposure levels of people.”

According to the study, there could be a link between people with blood type A’s higher susceptibility of contracting the Covid-19 virus and the presence of natural antibodies in the blood, but added that more studies were needed to prove the link.

The comparison above therefore points out that although there are slight variations in figures between the normal population and those with Covid-19, it’s premature to conclude that people with blood type O are entirely immune to contracting the virus, nor does it mean that everyone who contracts the virus will be type A.

However, the researchers urged governments and medical professionals to consider this factor when treating infected patients.

*As of 25 March 2020, there are 709 confirmed cases of the new coronavirus in South Africa. Find all the updates here.

Image: Ekachai Lohacamonchai/Getty

Share Button

Coronavirus: Home tests won’t be available ‘next week’

The UK’s chief medical adviser said they had to be confident which tests worked first.

Share Button

Health24.com | The other side of coronavirus – milder cases, recovery and getting back to health

The coronavirus pandemic has caused a worldwide shift in the way people live, placing many in self-imposed exile to prevent the spread of the contagion.

But it’s important to remember that four out of every five infected people will have mild symptoms, perhaps so mild as to not be noticeable, experts note.

“About 80% of people get a very mild illness and they recover uneventfully. That’s important to realise,” said Dr Robert Glatter, an emergency medicine physician with Lenox Hill Hospital in New York City.

Another 15% of people infected with coronavirus have more serious symptoms, and 5% develop life-threatening illness, experts say.

‘Of course I’m worried’

The actor Idris Elba is possibly the most famous mild Covid-19 case in the world. Elba tested positive for coronavirus after being exposed to another infected person, but says he did not have any symptoms.

Still, Elba has asthma, and in a live Twitter chat this week said he’s worried how the virus might affect him in the days ahead.

“Yes, of course I’m worried. I’m worried about having asthma and how that could make things complicated very quickly,” Elba said.

That’s not an insignificant concern. People with a minor case of Covid-19 will wrangle with mild symptoms for a week to 10 days, but their cases can worsen.

Dr Aaron Glatt, chair of medicine at Mount Sinai South Nassau in New York, said, “We have some general data that suggest people who get symptomatic for a short period of time, it can progress and they can be sicker for a week or even two weeks.”

The way the virus operates within the body gives most people a good chance of developing only mild illness, Glatter said.

The coronavirus tends to shed a lot early in Covid-19 infection, which “is actually good because it produces high levels of [immune system] antibody that are protective,” Glatter said.

Antibodies are protective

Glatter compared Covid-19 to SARS (severe acute respiratory syndrome), which put the world in a panic in 2002–2003 and had a much higher death rate. That’s because the virus peaked later in the disease, after it had moved into the lungs.

“When you shed virus at high levels early on, you build antibodies and the antibodies are protective,” Glatter said. “With Covid-19, you shed much earlier in the first days of disease, not when severe lung disease has developed.”

Seattle resident Elizabeth Schneider falls into the 15% of people with more serious symptoms that were still manageable at home.

Schneider suspects she contracted the virus at a house party on 22 February, she told CNN. Within three days, she felt fatigued and suffered from body aches and headache. Her temperature rose as high as 103 degrees Fahrenheit (39.44 degrees Celsius).

Schneider tested positive for coronavirus, but recovered after staying home, resting and taking over-the-counter remedies.

“I think the big takeaway I want to tell everyone is: Please don’t panic,” Schneider said. “If you are healthy, if you are younger, if you take good care of yourself when you’re sick, you will recover, I believe. And I’m living proof of that.”

Two negative tests required

In general, older people are at higher risk for severe symptoms, but that’s not always the case, Glatt said. Chronic illnesses like obesity, lung problems and heart issues could make young people more likely to become sicker.

According to Glatt, “A healthy older person with good lungs and in good shape might be better off than a younger person with a heavy smoking history.”

People who have tested positive for Covid-19 should have two negative tests at least 24 hours apart before they’re considered no longer contagious, he said.

They shouldn’t assume that they now have immunity, however.

Ordinary coronavirus infections that cause the common cold do not produce lasting immunity, said Ira Longini, co-director of the Center for Statistics and Quantitative Infectious Diseases at the Emerging Pathogens Institute at the University of Florida in Gainesville.

“You can be infected over and over, and we really don’t know for this novel coronavirus if that’s also true,” Longini said. “There is some anecdotal evidence already of re-infections, but we really don’t know.”

Many more mild cases

There’s also some strong concern that minor cases are driving the Covid-19 pandemic, because people aren’t sick enough to know they’re contagious.

About 86% of Covid-19 cases in China went undetected during the two-week ramp up of the epidemic in January, prior to the country implementing travel restrictions, researchers reported this week in the journal Science.

Mild cases are about half as infectious as those with more severe symptoms, said senior researcher Jeffrey Shaman, a professor of environmental health sciences at Columbia University Mailman School of Public Health, in New York City.

But because there are so many more mild cases, they “are driving the spread and growth of the outbreak”, Shaman said.

“The virus thrives off the ability for people to mingle and meet each other,” Shaman said. “Coming into contact unnecessarily at this point is something that people should really consider restricting.”

READ | Coping with cancer during the coronavirus pandemic

READ | Could cononavirus survivors’ blood help save very ill patients?

READ | FAKE NEWS on WhatsApp: Coronavirus, doctors from Vienna and ‘killer’ ibuprofen

Image credit: Getty Images

Share Button

Health24.com | What does self-quarantine to prevent the spread of coronavirus look like?

Many are choosing, or have been told to, self-quarantine to slow the spread of the new coronavirus.

Doctors at the University of Texas Health Science Center at Houston broke down what that is supposed to look like.

Isolation separates sick people from those who are not sick, while quarantine restricts the movement of people exposed to a contagious disease to monitor if they become sick, said Dr Luis Ostrosky, a professor of infectious diseases.

His colleague, Dr Susan Wootton, an infectious disease paediatrician, explains how to self-quarantine:

  • Separate yourself from people and pets in your home.
  • Stay home unless you are seeking medical attention.
  • Call your doctor before visiting.
  • Only wear a face mask if you are sick.
  • Wash your hands and clean “high-touch” surfaces such as doorknobs, toilet handles and remote controls.
  • Cover coughs and sneezes.
  • Do not share personal household items.
  • Monitor your symptoms.
  • Check with healthcare providers before you stop quarantining.

It is especially important to monitor your health if you may have had close contact with a person who has been exposed to or developed Covid-19. Symptoms include fever, cough and trouble breathing.

“Infection control and prevention efforts by patients with Covid-19, their household members and their health care providers, in combination with contact tracing activities, are key to limiting the community spread of disease,” Wootton said in a university news release.

Image credit: iStock

Share Button

3 ways to avoid secondhand smoke

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Mayo Clinic Marketplace

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Share Button

High-efficiency laser for silicon chips

Transistors in computer chips work electrically, but data can be transmitted more quickly by using light. For this reason, researchers have long been looking for a way to integrate lasers directly in silicon chips. Scientists from Forschungszentrum Jülich have now come a step closer to achieving this. Together with researchers from Centre de Nanosciences et de Nanotechnologies (C2N) in Paris and the French company STMicroelectronics as well as CEA-LETI Grenoble, they have developed a compatible semiconductor laser made of germanium and tin, whose efficiency is comparable with conventional GaAs semiconductor lasers on Si.

Optical data transfer permits much higher data rates and ranges than current electronic processes while also using less energy. Computation and data centres, therefore, already default to optical fiber whenever cables exceed a length of about one metre. In future, optic solutions will be in demand for shorter and shorter distances due to increasing requirements, for example board to board or chip to chip data transfer. This applies particularly to artificial intelligence (AI) systems where large data volumes must be transferred within a large network in order to train the chip and the algorithms.

“The most crucial missing component is a cheap laser, which is necessary to achieve high data rates. An electrically pumped laser compatible with the silicon-based CMOS technology would be ideal,” explains Prof. Detlev Grützmacher, director at Forschungszentrum Jülich’s Peter Grünberg Institute (PGI-9). “Such a laser could then simply be shaped during the chip manufacturing process since the entire chip production is ultimately based on this technology.”

But there is one problem: pure silicon is an “indirect semiconductor” and, therefore, unsuitable as a laser material. Different materials are currently used for manufacturing lasers. Generally, III-V compound semiconductors are used instead. “Their crystal lattice, however, has a completely different structure than that of silicon, which is a group IV element. Laser components are currently manufactured externally and must be integrated subsequently, which makes the technology expensive,” explains Grützmacher.

In contrast, the new laser can be manufactured during the CMOS production process. It is based on germanium and tin, two group IV elements like silicon. Back in 2015, Jülich researchers showed that laser emission can be obtained in GeSn system. The decisive factor in this is the high tin content: back then, it amounted to 12 %, which is far above the solubility limit of 1 % .

“Pure germanium is, by its nature, an indirect semiconductor like silicon. The high concentration of tin is what turns it into a direct semiconductor for a laser source,” explains Dr. Dan Buca, working group leader at Jülich’s Peter Grünberg Institute (PGI-9).

The patented epitaxial growth process developed by Jülich is used by several research groups all over the world. By further increasing the tin concentration, lasers have already been made that work not only at low temperatures but also at 0°C.

“A high tin content, however, decreases the laser efficiency. The laser then requires a relatively high pumping power. At 12-14 % tin, we already need 100-300 kW/cm2,” explains Nils von den Driesch. “We thus tried to reduce the concentration of tin and compensate this by additionally stressing the material, which considerably improves the optical properties.”

For the new laser, the researchers reduced the tin content to approximately 5 % — and simultaneously decreased the necessary pumping power to 0.8 kW/cm2. This produces so little waste heat that this laser is the first group IV semiconductor laser that can be operated not only in a pulsed regime but also in a continuous working regime, i.e. as a “continuous-wave laser.”

“These values demonstrate that a germanium-tin laser is technologically feasible and that its efficiency matches that of conventional III-V semiconductor lasers grown on Si. This also brings much closer to an electrical pumped laser for industrial-application that works at room temperature,” explains institute head Grützmacher. The new laser is currently limited to optical excitation and low temperatures of about -140°C.

Such a laser would be interesting not only for optical data transfer but also for a variety of other applications since there are hardly any cheap alternatives for the corresponding wavelengths in the infrared range of 2-4 ?m. Potential applications range from infrared and night-vision systems all the way to gas sensors for monitoring the environment in climate research or even breath gases analyses for medical diagnosis.

Share Button